ArticleScientific reports2025
Life course socioeconomic position and the risk of cardiovascular events and all-cause mortality in a Norwegian twin study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Socioeconomic disadvantage throughout life is associated with an increased risk of cardiovascular diseases (CVD) and all-cause mortality. However, the extent to which common familial genetic and environmental factors explain this association is unclear. This study investigates family- and individual-specific effects on this association using twin data. Data from 21,051 twins were linked to census and registry data on 20 indicators of socioeconomic position (SEP) from 1960 to 1990, with follow-up on hospital discharges and causes of death until 2018. A graded item response model was used to aggregate SEP indicators into a linear scale, divided into quintiles. Hazard ratios were estimated using a mixed-effects Weibull proportional hazard regression model. At the familial level, higher SEP quintiles were associated with a lower risk of CVD events (HR = 0.51 for monozygotic [MZ] twins, HR = 0.56 for dizygotic [DZ] twins). Individual-specific effects showed hazard ratios of 0.80 for MZ twins and 0.73 for DZ twins. For all-cause mortality, familial risks for the top two quintiles were HR = 0.64 in MZ twins and HR = 0.61 in DZ twins, with individual-specific effects at HR = 0.71 in MZ twins and HR = 0.74 in DZ twins. The associations between life course SEP and both CVD and all-cause mortality are partly explained by shared familial factors from early life, with shared genetic factors having minimal additional influence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.